INTRODUCTION
============

Preterm birth (PTB), defined as birth occurring before the completion of 37 weeks of gestation, is currently a priority in obstetrics and perinatal care owing to its association with neonatal death and long-term morbidity ([@B01]). The estimated global rate of PTB is 10.6% of all pregnancies. In Latin America, PTB leads to complications in 9.8% of all pregnancies. Brazil has the ninth highest PTB rate (11.2%) ([@B02]). PTB is also the leading cause of perinatal mortality. Surviving children are more likely to develop sequelae in the medium and long terms, including cerebral palsy, developmental delay, and retinopathy of prematurity, at a rate of 50--75% ([@B01]). PTB has a great impact on pregnant women and their relatives, increasing their anxiety and emotional stress levels ([@B03]).

One of the main questions is whether preterm labor and PTB can be predicted in low-risk pregnancies. PTB is a multifactorial syndrome. Potential risk factors such as low socioeconomic status, smoking, periodontitis, previous PTB, and multiple pregnancies have been previously identified. Additional factors are yet to be identified, but could be useful for the identification of women at increased risk for PTB ([@B04]). To identify the possible causes of PTB, it is necessary to differentiate between elective or provider-initiated PTB, resulting from interventions to interrupt pregnancy due to a maternal or fetal condition, and PTB after premature rupture of membranes (PROM) or due to spontaneous preterm labor, which may account for up to 50% of PTBs ([@B05]).

Some factors seem to be related to a high-risk phenotype for spontaneous PTB (sPTB), including extrauterine infection, maternal chronic disease, mid/late pregnancy bleeding, multiple pregnancy, clinical chorioamnionitis, and antepartum stillbirth. However, the majority of sPTBs occur in women with no previously identified risk factors ([@B06]).

Infection is present in up to 25% of preterm labor and 79% of extreme PTBs ([@B05]). Infectious and inflammatory processes are related to worse prognosis in preterm labor, increasing failure of tocolytic therapy, leading to higher delivery rates within 48h. PTB may actually be the only manifestation of microbial invasion of the amniotic cavity ([@B06]). Nevertheless, infections at other remote sites, e.g., urinary or periodontal infections, are also associated with sPTB ([@B07]). Inflammatory cytokines can be detected in cord blood samples collected from preterm neonates with confirmed chorioamnionitis, probably due to an altered placental and membrane microbiome that seems to trigger the onset of preterm labor and PROM ([@B08]).

Therefore, this study aimed to evaluate the development and causes of maternal infection and its association with maternal and neonatal outcomes in women with sPTB from different Brazilian regions.

METHODS
=======

This is a secondary analysis of the Brazilian Multicentre Study on Preterm Birth (EMIP) conducted from April 2011 to July 2012. EMIP was a multicenter cross-sectional study with a nested case--control component. The study protocol and main results have been previously reported ([@B09]-[@B12]). Currently, this analysis focuses on the development of maternal infection, type of PTB, and factors possibly associated with maternal infection and neonatal outcomes (fetal and neonatal mortality, Apgar score, birth weight, intubation, use of surfactant, neonatal intensive care unit (NICU) admission, ventilatory support, neonatal morbidity, neonatal sepsis, cerebral hemorrhage, and necrotizing enterocolitis).

Briefly, EMIP included all PTBs from April 2011 to July 2012 in 20 referral obstetric hospitals from different regions of Brazil. A random sample of women without PTB was also included in the case--control arm of the study. Data were obtained by interviewing women who had delivered during the study period while they were still in the hospital. Further information was collected from the medical records of these patients. Therefore, the criterion used for assessing maternal infection (vulvovaginitis, urinary tract infection, or dental infection) was any self-reported infectious condition or any infection identified through prenatal or hospital clinical records. Data were entered and stored in an electronic database (OpenClinica^®^), which allowed access to the entire data on all participants. Data on maternal characteristics such as age, ethnic background, obstetric history, history of infection or active infection, current treatment, chronic disease, and partnership were collected. Information on perinatal outcomes was also obtained.

All centers were included in the study only after their respective institutional review boards had approved the research project. Information from women and their neonates was collected after these women provided written informed consent. The study protocol complied with the principles applying to human research, established by the Brazilian National Health Council Resolution.

EMIP followed 33,740 women and enrolled 5,296 women, including 4,150 preterm cases (1,491 cases of sPTB, 1,191 cases of pre-labor PROM \[pPROM\], and 1,468 cases of provider-initiated PTB). In the current analysis, only women with sPTB and those with pPROM were included, totaling 2,682 women. Among PTB cases, two groups were identified: women with at least one infectious factor and women who did not present any evidence or self-report of maternal infection.

The analytical approach aimed to descriptively estimate the prevalence of different types of maternal infectious diseases and their relationship with PTB and assess the possible associated factors, type of PTB, gestational age at birth, and neonatal outcomes associated with maternal infection, compared to those in neonates born to women with no evidence of infectious diseases. A bivariate analysis was performed to identify possible individual risk factors for some maternal infections in PTBs. The odds ratios (ORs) adjusted using the cluster design effect with their respective 95% confidence intervals were estimated. SPSS and Stata packages were used for the analysis. The level of significance adopted was 0.05.

RESULTS
=======

In EMIP, the prevalence rate of PTB was 12.3% (4,150 cases in 33,740 deliveries), and sPTB or pPROM accounted for 64.6% (2,682) of these births and were included in our secondary analysis.

Among women included in the study, the majority fulfilled at least one criterion for the identification of maternal infection (65.9%) ([Figure 1](#f01){ref-type="fig"}). In some cases, the same woman had two or more criteria for infectious disease. [Table 1](#t01){ref-type="table"} shows the distribution of women with PTB who had signs of maternal infection, type of infection, and its respective prevalence. More than 50% of these women reported urinary tract infection during pregnancy and 35% had their treatment documented on medical charts.

Many women reported vaginal discharge consistent with vulvovaginitis at some stage in pregnancy (57.3%), although this diagnosis had been recorded in the medical charts of less than half of patients (26.9%). [Table 1](#t01){ref-type="table"} also shows the distribution of patients according to infectious agents identified in documented cases of vulvovaginitis. Of 455 cases of periodontal infection, 287 (63%) fulfilled more than one criterion for maternal infection. Therefore, 168 women (37%) were classified as having maternal infection based on periodontal disease alone, accounting for 9.6% of the total sample of 1741 women with PTB and maternal infection.

[Table 2](#t02){ref-type="table"} shows the distribution of some sociodemographic data of women with and without maternal infection. Having a partner was more frequent among women with maternal infection (77.0% *vs*. 72.3%; *p*=0.026; OR, 1.28 \[1.03-1.59\]). Other characteristics such as maternal age, ethnicity, family income, initial and final body mass index, and place of living did not show any significant differences between groups.

A comparison between the type of sPTB and maternal infection is shown in [Table 3](#t03){ref-type="table"}. Among women with maternal infection, 54.9% had sPTB, while 45.1% had pPROM. Conversely, 66.8% of women with pPROM had infection. Moreover, the distribution of the causes of PTB was similar among women with and without infection.

Gestational age at the time of PTB was similar among women with and without infection, and the majority of PTBs occurred after 34 weeks of gestation. When analyzing cases of sPTB and pPROM separately, there was no difference between both groups. Furthermore, in both groups, it was observed that most PTBs occurred after 34 weeks ([Table 4](#t04){ref-type="table"}).

No difference in evaluated neonatal outcomes was observed between women with and without maternal infection, as shown in [Table 5](#t05){ref-type="table"}. In the total of cases, there was a high prevalence rate of birth weight \<2.500 g and neonatal morbidity. Additionally, 9% of neonates included in the study had a 5-min Apgar score \<7, and neonatal sepsis was noted in one-third of all included neonates, and 10% stayed in the NICU for \>28 days. The fetal death rate in our study was approximately 2.5% ([Table 5](#t05){ref-type="table"}).

DISCUSSION
==========

Our results did not show any significant differences in the neonatal outcomes of preterm neonates between women with or without screened infections. There was also no specific association between different types of spontaneous prematurity and presence of maternal infection. It seems that sociodemographic conditions do not influence the incidence of maternal infection, except for marital status, which was more highly associated with the development of infection in women with a partner.

It is probable that other conditions may be more important in determining neonatal outcomes, apart from a simple diagnosis of infectious disease during pregnancy. Gestational age at the time of infection, quality of neonatal care, corticosteroid administration, and other labor-related factors may be implicated in determining the overall neonatal outcome. In contrast, the prevalence rate of neonatal sepsis in our study was much higher than that reported in other studies ([@B13]). Nevertheless, it is recognized that neonatal sepsis is underreported owing to the discrepancies in its definition and surveillance worldwide ([@B12],[@B13]). Additionally, in a recent study performed in the south of Brazil, a neonatal sepsis rate of 30.7% was responsible for neonatal mortality, which is also a high rate ([@B14]).

Furthermore, the diagnosis of maternal infection in a woman with preterm labor does not necessarily imply that it is the only cause of prematurity. It is also worth mentioning that PTB may be related to asymptomatic or occult infection ([@B13]) or even due to colonization by infectious agents without infection, e.g., group B streptococcal colonization ([@B15]). In our sample, we divided women according to the clinical development of infection, and there were no data on maternal colonization or development of asymptomatic or occult infection. The very existence of these conditions could trigger preterm labor and be responsible for the evaluated neonatal outcomes.

It is noteworthy that the criteria used for maternal infection involved only aspects that could be clinically identified during obstetric care in all participating centers. The detection of maternal infection remains of utmost importance for the prevention of preterm labor, as shown in the EMIP ([@B10]) with either bacterial vaginosis or urinary tract infection identified as risk factors for sPTB. However, it seems that maternal infection has no influence on worse neonatal outcomes. Our data support that these preterm neonates require no additional care beyond what is usually offered to preterm neonates in general.

One of the infections most commonly associated with PTB is chorioamnionitis, which is often misdiagnosed because of an asymptomatic clinical presentation ([@B13]). In this study, this condition was not specifically evaluated. As a result, information on its prevalence rate is inadequate in this population. Moreover, puerperal infection was not evaluated among study participants. We do recognize that this is one of the possible limitations of this study regarding infection, as is the case of the criteria used for identifying infection.

Our results showed a high prevalence of maternal infection among women included in the study. The high rate results from the analysis of a particular group of women with preterm labor. In part, this result was obtained because the criteria adopted for the identification of maternal infection involved self-reported data. As expected, the percentage of self-reported treatment for vaginal discharge was much higher than that in patient medical records. The prevalence of vaginal discharge in our study was much higher than those previously reported ([@B16]), and we could not assess the pathogen associated with infection. Another study conducted elsewhere reported that vulvovaginal candidiasis was the most prevalent cause of vaginal discharge ([@B17]).

It is difficult to determine which number is correct (self-referred or documented information). Nevertheless, the difference reveals the importance of careful evaluation of infectious conditions during pregnancy that may have underestimated prevalence rates in healthcare services across the country. Moreover, these differences also reveal that the quality of information in the medical records is far from being complete and totally reliable, and this represents another limitation of this current study.

In this study, maternal outcomes were not evaluated. Therefore, conclusions regarding the potential aggravation of puerperal outcomes due to maternal infection could not be drawn.

Further, this was a secondary analysis of a cohort with a sample size empowered to analyze all causes of PTBs, which failed to consider specific causes of that event, and our sample may be unpowered. Additionally, data were obtained after maternal interview, and some information may have been inaccurate. In contrast, the EMIP study was conducted in different Brazilian settings. It covered a large number of deliveries, including almost all preterm deliveries occurring in those settings during that period.

We believe that a more detailed approach is needed to strengthen the correlation between infectious processes and PTB. Furthermore, it is necessary to gain better understanding of the changes occurring in the intrauterine environment and their consequences to preterm neonates. Even if maternal infection is unrelated to PTB, we cannot dismiss the condition in clinical practice owing to its hazardous effects on maternal health. Therefore, early detection and treatment of asymptomatic or occult infection, including urinary tract infection and chorioamnionitis, is important.
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###### Distribution of women who had preterm birth according to the development of maternal infection, type, and treatment.

  Conditions                                                         n                                          \%
  ------------------------------------------------------------------ ------------------------------------------ -------
  Maternal infection                                                                                            
      Yes                                                            1741                                       65.9
      No                                                             902                                        34.1
  Total^a^                                                           2643                                       100.0
  Type of infection                                                                                             
      Self-reported treatment for vaginal discharge^b^               997                                        57.3
      *Vulvovaginitis* mentioned in clinical records                 469                                        26.9
          Bacterial vaginosis                                        240                                        13.8
          Candidiasis                                                212                                        12.2
          Trichomoniasis                                             30                                         1.7
          Others                                                     19                                         1.1
      Treatment for *vulvovaginitis* mentioned in clinical records   421                                        24.2
      Self-reported treatment for UTI^c^                             995                                        57.2
      Treatment for UTI mentioned in clinical records                622                                        35.7
      Self-reported dental infection^d^                              455                                        26.1
  Total                                                              1741[\*](#TFN02t01){ref-type="table-fn"}   100.0

Missing information for ^a^39, ^b^4, ^c^13, and ^d^10 women.

The same women may have fulfilled more than one criterion for maternal infection.

UTI, urinary tract infection.

###### Distribution of women with preterm birth according to sociodemographic characteristics based on the presence of maternal infection.

                                        Maternal infection^a^                              
  ------------------------------------- ----------------------- -------------- ----------- ------------------------
  Maternal age - mean (SD)              25.0 (6.85)             25.2 (6.95)    0.575       1.00 \[0.98-1.01\]
  From urban area (%)^b^                89.4                    91.2           0.183       0.82 \[0.61-1.11\]
  White (%)                             43.1                    43.1           0.996       1.00 \[0.86-1.17\]
  With partner (%)                      77.0                    72.3           **0.026**   **1.28 \[1.03-1.59\]**
  Family income \>R\$ 2.000,00 (%)^c^   10.3                    12.0           0.167       0.94 \[0.87-1.03\]
  Initial BMI - mean (SD)^d^            23.55 (5.07)            23.48 (4.71)   0.713       1.00 \[0.98-1.02\]
  Final BMI - mean (SD)^e^              27.51 (5.33)            27.29 (5.19)   0.501       1.01 \[0.99-1.03\]
  Total^a^                              1741                    902                        

Missing information for ^a^39, ^b^13, ^c^239, ^d^360, and ^e^457 women.

OR~adj~, odds ratio adjusted using the cluster design effect.

###### Distribution of women according to the type of preterm birth (spontaneous preterm birth and preterm premature rupture of membranes) based on the presence of maternal infection.

                        Maternal infection                        
  --------------------- -------------------- ------------ ------- --------------------
  Spontaneous PTB (%)   956 (54.9)           511 (56.7)   0.204   0.93 \[0.83-1.04\]
  pPROM (%)             785 (45.1)           391 (43.3)           1.00
  Total                 1741                 902                  

OR~adj~, odds ratio adjusted using the cluster design effect.

###### Distribution of women with preterm birth according to gestational age at delivery and type of PTB based on the presence of maternal infection.

                             Maternal infection          
  ----------- -------------- -------------------- ------ --------------------
  sPTB^p1^    \<32 weeks     20.7                 23.9   1.00
              32--33 weeks   13.4                 15.7   0.99 \[0.64-1.52\]
              \>34 weeks     65.9                 60.5   1.26 \[0.92-1.72\]
  pPROM^p2^   \<32 weeks     17.3                 19.2   1.00
              32--33 weeks   14.9                 17.4   0.95 \[0.67-1.35\]
              \>34 weeks     67.8                 63.4   1.18 \[0.93-1.51\]
  Total^p3^   \<32 weeks     19.2                 21.8   1.00
              32--33 weeks   14.1                 16.4   0.98 \[0.72-1.32\]
              \>34 weeks     66.7                 61.8   1.23 \[0.96-1.57\]

*p* ~1~=0.171; *p* ~2~=0.198; *p*=0.078.

pPROM, pre-labor premature rupture of membranes; sPTB, spontaneous preterm birth.

OR~adj~, odds ratio adjusted using the cluster design effect.

###### Distribution of women who had preterm birth according to neonatal results and presence of maternal infection (in percentage).

                                   Maternal infection          
  -------------------------------- -------------------- ------ -------
  Birth weight \<2.500 g           68.0                 71.6   0.135
  Apgar score at 1 min \<7         23.8                 26.2   0.196
  Apgar score at 5 min \<7         9.1                  9.4    0.881
  Fetal death                      2.1                  3.2    0.098
  Intubation                       14.7                 16.9   0.200
  Use of surfactant                13.6                 15.9   0.092
  NICU admission \>28 days         9.9                  10.0   0.982
  Total time admission \>28 days   15.1                 15.4   0.809
  Ventilatory support              48.8                 46.8   0.493
  Neonatal morbidity               69.1                 66.4   0.343
  Neonatal sepsis                  29.7                 31.5   0.399
  Cerebral hemorrhage grade zero   9.3                  9.6    0.870
  Necrotizing enterocolitis        1.7                  3.1    0.106
  Any of the above outcome         84.9                 86.9   0.261
